| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to pharmaceutical industry, namely to medicated products normalising cardiac function, particularly being perspective for treatment of coronary heart disease (CHD). Peptide of general formula CH 3 CO-Lys-Lys-Arg-Arg-NH 2 is disclosed as an anti-ischemic and antihypoxic agent. n EFFECT: declared invention ensures apparent anti-ischemic, antihypoxic and adaptive action and is being available in medical practice. n 1 cl, 3 ex, 5 tbl |